You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chlorambucil

Showing 1 - 25 of 106
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MALT Lymphoma Trial in France, Italy, Switzerland (Chlorambucil, Rituximab i.v., Rituximab s.c.)

Active, not recruiting
  • MALT Lymphoma
  • Chlorambucil
  • +2 more
  • Créteil, France
  • +37 more
Nov 4, 2022

Untreated Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Rituximab, Chlorambucil)

Recruiting
  • Untreated Chronic Lymphocytic Leukemia
  • Beijing, China
  • +50 more
Sep 26, 2022

Gazyva Infusion Reaction Investigation

Recruiting
  • Chronic Lymphocytic Leukemia
    • Moscow, Russian Federation
    • +1 more
    Feb 11, 2022

    Pancreatic Ductal Adenocarcinoma Trial in Milan (Chlorambucil, Oral, 2 Mg)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Chlorambucil, Oral, 2 Mg
    • Milan, Italy
      IRCCS San Raffaele
    Dec 30, 2020

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (ICP-022, Chlorambucil, Rituximab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Bengbu, Anhui, China
    • +55 more
    Mar 25, 2022

    B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Chlorambucil, Obinutuzumab, Placebo)

    Terminated
    • B-Cell Chronic Lymphocytic Leukemia
    • Chlorambucil
    • +4 more
    • Haifa, Israel
    • +13 more
    Apr 6, 2021

    Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)

    Active, not recruiting
    Has Results
    • Lymphocytic Leukemia, Chronic
    • Chlorambucil
    • +2 more
    • Duarte, California
    • +136 more
    Dec 22, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Obinutuzumab
    • +3 more
    • Huntsville, Alabama
    • +153 more
    Aug 19, 2022

    Chronic Lymphocytic Leukemia Trial in Huntsville, Memphis (TGR-1202 + Obinutuzumab + Chlorambucil)

    Completed
    • Chronic Lymphocytic Leukemia
    • TGR-1202 + Obinutuzumab + Chlorambucil
    • Huntsville, Alabama
    • +1 more
    Oct 1, 2019

    Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small-Cell Lymphoma
    • La Jolla, California
    • +70 more
    Aug 27, 2020

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Post-Chlorambucil Therapy Follow-up
    • +4 more
    • Duarte, California
    • +106 more
    Aug 6, 2021

    Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

    Completed
    Has Results
    • Indolent Non-Hodgkin's Lymphoma
    • +2 more
    • Huntsville, Alabama
    • +10 more
    Feb 22, 2021

    Marginal Zone Lymphoma Trial in Germany (Obinutuzumab)

    Active, not recruiting
    • Marginal Zone Lymphoma
    • Bochum, Germany
    • +15 more
    Nov 4, 2022

    Chronic Lymphocytic Leukemia Trial in Hwasun (Obinutuzumab)

    Unknown status
    • Chronic Lymphocytic Leukemia
    • Hwasun, Jeollanam-do, Korea, Republic of
      Chonnam National University Hwasun Hospital
    Aug 15, 2019

    Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

    Not yet recruiting
    • Marginal Zone Lymphoma
    • Mosunetuzumab + Lenalidomide
    • +3 more
    • (no location specified)
    Aug 16, 2023

    Patient Perspectives in Mantle Cell Lymphoma Clinical Research

    Not yet recruiting
    • Mantle Cell Lymphoma
      • San Francisco, California
        Power Life Sciences
      Sep 15, 2023

      MALT Trial in Worldwide (chlorambucil (drug), rituximab+chlorambucil, rituximab)

      Completed
      Has Results
      • Lymphoma, Mucosa-Associated Lymphoid Tissue
      • chlorambucil (drug)
      • +2 more
      • Antwerpen, Belgium
      • +74 more
      Mar 1, 2019

      Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

      Not yet recruiting
      • Idiopathic Membranous Nephropathy
      • (no location specified)
      Aug 22, 2022

      Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • (no location specified)
      Jul 10, 2023

      Lymphocytic Leukemia, Chronic Trial in Russian Federation (Chlorambucil, Cyclophosphamide, Fludarabine)

      Terminated
      Has Results
      • Lymphocytic Leukemia, Chronic
      • Chlorambucil
      • +3 more
      • Irkutsk, Russian Federation
      • +7 more
      Nov 23, 2018

      Chronic Lymphocytic Leukemia Trial in Italy (Lenalidomide; Chlorambucil)

      Terminated
      Has Results
      • Chronic Lymphocytic Leukemia
      • Lenalidomide; Chlorambucil
      • Brescia, Italy
      • +9 more
      Jan 24, 2019

      Marginal Zone Lymphoma Trial in Austria, Germany (Copanlisib, Rituximab)

      Recruiting
      • Marginal Zone Lymphoma
      • Wien, Austria
      • +19 more
      Mar 14, 2022

      Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

      Completed
      • Leukemia, Lymphocytic, Chronic
      • Dresden, Germany
      • +10 more
      Jan 13, 2023

      Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)

      Active, not recruiting
      • Relapsed Diffuse Large B-Cell Lymphoma
      • Refractory Diffuse Large B-Cell Lymphoma
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Oct 7, 2022

      Leukaemia, Lymphocytic, Chronic Trial in Worldwide (chlorambucil, tablets, ofatumumab (GSK1841157) infusion)

      Terminated
      Has Results
      • Leukaemia, Lymphocytic, Chronic
      • chlorambucil, tablets
      • ofatumumab (GSK1841157) infusion
      • Sedona, Arizona
      • +153 more
      Jun 5, 2019